To include your compound in the COVID-19 Resource Center, submit it here.

AZ's Imfinzi gets breakthrough therapy designation for NSCLC

AstraZeneca plc (LSE:AZN; NYSE:AZN) said FDA granted breakthrough therapy designation

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE